American Century Companies’s Immunovant IMVT Stock Holding History

American Century Companies’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,352	Closed	-$207K	–	2812
2023 Q1	$207K	Sell	13,352 -352	-3%	-$6.11K	﹤0.01%	2409
2022 Q4	$243K	Buy	+13,704	New	+$173K	﹤0.01%	2283
2021 Q4	–	Sell	-250,854	Closed	-$2.18M	–	2344
2021 Q3	$2.18M	Buy	250,854 +112	+0%	+$1.01K	﹤0.01%	1286
2021 Q2	$2.65M	Buy	250,742 +1,431	+0.6%	+$20K	﹤0.01%	1155
2021 Q1	$4M	Buy	+249,311	New	+$6.57M	﹤0.01%	994

Other funds holding IMVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

American Century Companies's IMVT Position: Q2 2023 in Review

American Century Companies sold out of Immunovant (IMVT) in Q2 2023, closing a stake of 13,352 shares — an estimated $207K sold.

American Century Companies first reported a position in IMVT in Q1 2021 and held it in 5 quarters. The position peaked at $4M in Q1 2021. 147 funds tracked by Wall St. Rank hold IMVT as of Q2 2023.

American Century Companies reported no remaining Immunovant position as of Q2 2023 after selling out during the quarter.
American Century Companies sold 13,352 Immunovant shares in Q2 2023, an estimated $207K.
American Century Companies first reported a position in Immunovant in Q1 2021 and held it in 5 quarters.
American Century Companies's Immunovant position peaked at $4M in Q1 2021.
147 funds tracked by Wall St. Rank held Immunovant as of Q2 2023.

Based on American Century Companies's 13F filing for Q2 2023, filed 14 Aug 2023.